GleamWall
中文EN

SBC SBC Medical Group Holdings Inc

Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 1930313 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.7%
TTM net income YoY19.8%
TTM EPS YoY21.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin72.2%
Operating margin39.9%
Net margin27.3%
FCF margin52.6%
EBITDA margin41.1%

Returns

ROE19.4%
ROA13.9%
ROIC (approx.)37.5%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets28.6%
Debt / equity0.12x
Current ratio3.67x
Interest coverage181.93x

Cash quality & payout

Operating cash flow / net income1.97x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$58.58M$49.19M$43.06M$39.57M$43.35M$43.36M$47.33M$44.42M
Cost of revenue$16.40M$13.21M$12.71M$10.64M$12.74M$13.35M$9.60M$10.55M
Gross profit$42.18M$35.98M$30.35M$28.93M$30.61M$30.01M$37.73M$33.87M
SG&A expense$15.76M$17.02M$12.63M$16.08M$14.73M$15.46M$13.53M$13.88M
Operating income$26.42M$18.96M$17.72M$12.85M$15.88M$14.55M$24.20M$4.72M
Interest expense$126,740$126,108$111,860$52,752$44,851$46,674$3,961$12,402
Pretax income$26.38M$19.55M$18.86M$18.57M$18.51M$13.54M$31.45M$6.06M
Income tax$9.38M$7.82M$7.53M$4.29M$5.67M$11.10M$9.96M-$488,553
Net income$15.69M$10.69M$11.31M$14.20M$12.82M$2.46M$21.50M$6.54M
EBITDA$26.91M$19.40M$18.39M$13.52M$16.33M$15.12M$24.83M$5.65M
EPS (basic)0.150.100.11—0.120.020.21—
EPS (diluted)0.150.100.11—0.120.020.21—
Weighted avg. shares (diluted)102.58M102.58M102.58M—102.64M103.51M103.28M—
Balance sheet
Cash & equivalents$198.43M$184.31M$167.31M$163.77M$127.43M$152.74M$132.06M$125.04M
Short-term investments$318,297$307,922$313,865$319,193———$0
Inventory$2.95M$2.98M$2.32M$2.79M$1.68M$1.71M$1.69M$1.49M
Current assets$273.86M$259.39M$238.78M$231.22M$227.20M$241.34M$215.10M$184.45M
PP&E, net$8.53M$7.41M$7.29M$7.54M$7.00M$8.06M$8.52M$8.77M
Goodwill$15.08M$15.18M$15.40M$15.43M$4.92M$5.01M$4.78M$4.61M
Intangibles$45.23M$45.69M$47.15M$47.74M$47.74M$1.58M$1.54M$1.59M
Total assets$424.82M$406.66M$388.02M$380.45M$321.36M$315.30M$284.61M$266.08M
Current liabilities$74.67M$78.46M$62.57M$61.12M$44.58M$60.68M$48.47M$61.19M
Short-term debt$201,722$203,512$219,601$228,210$250,489$266,573$266,011$262,095
Long-term debt$33.60M$37.75M$40.44M$42.83M$21.12M$7.10M$6.86M$6.60M
Total debt$33.80M$37.96M$40.65M$43.06M$21.37M$7.37M$7.13M$6.86M
Total liabilities$121.35M$126.74M$117.64M$117.14M$73.30M$70.65M$58.28M$71.06M
Shareholders' equity$286.85M$263.84M$255.34M$248.28M$247.99M$244.59M$226.45M$195.11M
Net debt-$164.62M-$146.35M-$126.65M-$120.71M-$106.06M-$145.37M-$124.92M-$118.18M
Shares outstanding102.58M102.58M102.58M102.58M102.58M103.10M103.61M102.75M
Cash flow statement
Operating cash flow$18.51M$22.51M$9.23M$51.96M-$20.88M-$8.34M$1.93M-$7.30M
Capital expenditure$1.01M$84,396$124,995$797,528$43,053$306,706$253,725$590,358
Free cash flow$17.50M$22.42M$9.11M$51.17M-$20.93M-$8.65M$1.67M-$7.89M
Investing cash flow-$5.08M$565,231-$528,025-$24.21M-$12.16M$16.38M-$978,807-$4.55M
Financing cash flow-$5.14M-$1.96M-$1.84M$19.82M$11.57M$7.18M-$280,380$11.38M
Depreciation & amortization$497,339$441,392$670,434$673,684$452,969$564,158$628,304$931,596
Stock-based compensation$11,687——$0$0——$215,237
Share buybacks$0——$0$2.58M——$0

Free plan shows the latest 8 periods; Pro shows all 17 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.